Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Utility of Amyloid Beta-peptide 1-40 Measurement in the Diagnosis of Alzheimer's Disease
NCT02770482Completed
- Sponsor
- CHU de Reims
- Start
- Jun 2014
- Primary completion
- Mar 2018
- Countries
- 1
01
Overview
Single-arm trial, sponsored by CHU de Reims. Primary endpoint: Percentage of diagnostic certitude for AD at 6 months. Started Jun 2014; status: completed.
Beyond the preview
Go deeper on NCT02770482.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02770482.